Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Journal for Immunotherapy of Cancer
|
September 13, 2022
Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)
Rick Daniel Vavolizza, Gina R Petroni, Ileana S Mauldin, et al.
Oncoimmunology
|
April 2, 2021
A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma
Craig L Slingluff, Hassane M Zarour, Hussein Abdul-Hassan Tawbi, et al.
Journal for Immunotherapy of Cancer
|
January 22, 2021
Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63)
Craig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2026
Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC)
Emily K Ninmer, Gina R Petroni, Brian R Gastman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2018
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma
Douglas B Johnson, Jennifer Bordeaux, Ju Young Kim, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study
Elizabeth M Gaughan, Miso Kim, Ignacio Mendez, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 17, 2024
Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity
John R Power, Charles Dolladille, Benay Ozbay, et al.
JACC. Cardiooncology
|
April 17, 2025
Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction
Yen-Chou Chen, Charles Dolladille, Anjali Rao, et al.
European Heart Journal
|
June 26, 2025
Immune checkpoint inhibitor-associated myocarditis: a novel risk score
John R Power, Charles Dolladille, Benay Ozbay, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Journal for Immunotherapy of Cancer
|
September 13, 2022
Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)
Rick Daniel Vavolizza, Gina R Petroni, Ileana S Mauldin, et al.
Oncoimmunology
|
April 2, 2021
A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma
Craig L Slingluff, Hassane M Zarour, Hussein Abdul-Hassan Tawbi, et al.
Journal for Immunotherapy of Cancer
|
January 22, 2021
Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63)
Craig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2026
Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC)
Emily K Ninmer, Gina R Petroni, Brian R Gastman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2018
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma
Douglas B Johnson, Jennifer Bordeaux, Ju Young Kim, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study
Elizabeth M Gaughan, Miso Kim, Ignacio Mendez, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 17, 2024
Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity
John R Power, Charles Dolladille, Benay Ozbay, et al.
JACC. Cardiooncology
|
April 17, 2025
Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction
Yen-Chou Chen, Charles Dolladille, Anjali Rao, et al.
European Heart Journal
|
June 26, 2025
Immune checkpoint inhibitor-associated myocarditis: a novel risk score
John R Power, Charles Dolladille, Benay Ozbay, et al.
Page
of 3